South Dakota · Senate

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

On HB 1099 — reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Passed 6 Yea · 0 Nay · 1 Other ·

By party

Party YeaNayPresentNot Voting
Republican 5001
Democratic 1000

How each member voted (7)